1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Tremor Global Clinical Trials Review, H2, 2014

Tremor Global Clinical Trials Review, H2, 2014

  • August 2014
  • -
  • GlobalData
  • -
  • 61 pages

Tremor Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Tremor Global Clinical Trials Review, H2, 2014" provides data on the Tremor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tremor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tremor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Tremor Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Tremor 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Tremor to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Tremor to Central Nervous System Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Tremor 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Tremor Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Veloxis Pharmaceuticals A/S 27
Clinical Trial Overview of Veloxis Pharmaceuticals A/S 27
Clinical Trial Overview of Top Institutes / Government 28
University of Alabama at Birmingham 28
Clinical Trial Overview of University of Alabama at Birmingham 28
National Institute of Neurological Disorders and Stroke 29
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 29
Boston Children's Hospital 30
Clinical Trial Overview of Boston Children's Hospital 30
Ohio State University 31
Clinical Trial Overview of Ohio State University 31
Emory University 32
Clinical Trial Overview of Emory University 32
Mayo Clinic 33
Clinical Trial Overview of Mayo Clinic 33
Syracuse University 34
Clinical Trial Overview of Syracuse University 34
Yazd Medical University 35
Clinical Trial Overview of Yazd Medical University 35
Mount Sinai Hospital 36
Clinical Trial Overview of Mount Sinai Hospital 36
University of California, Davis 37
Clinical Trial Overview of University of California, Davis 37
Five Key Clinical Profiles 38
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61

List of Tables
Tremor Therapeutics, Global, Clinical Trials by Region, 2014* 6
Tremor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tremor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tremor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Tremor Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Tremor Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Tremor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Tremor to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tremor Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tremor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tremor to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tremor Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Tremor Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Tremor Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Tremor Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Tremor Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Tremor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Tremor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Tremor Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Tremor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Tremor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Veloxis Pharmaceuticals A/S, 2014* 27
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 28
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 29
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014* 30
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2014* 31
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 32
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 33
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Syracuse University, 2014* 34
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yazd Medical University, 2014* 35
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014* 36
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014* 37

List of Figures
Tremor Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Tremor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tremor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tremor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Proportion of Tremor to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tremor Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tremor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tremor to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tremor Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Tremor Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Tremor Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Tremor Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Tremor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Tremor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Tremor Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Tremor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 60

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The Global market for Clinical Trial Management System is expected to reach $2 billion by the end of 2020 growing at a CAGR of around 12.5% from 2014 to 2021. Clinical Trial Management System is a system ...

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trials Market Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.